NewGen Announces Pricing of $1.25 Million Public OfferingBANGKOK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (
NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the Company expected to be approximately $1.25 million, before deducting placement agent fees and other offering expenses payable by the Company.
NewGenIVF Completes Exchange of Convertible Notes with Institutional InvestorRestructuring eliminates prior mandatory proceeds sweep and improves capital structure flexibility
NewGen Provides Update on K25.ai Investment and Strengthened Financial PositionNewGen’s total shares outstanding count expected to reach 5.9 million following recently announced share issuance, bolstering market capitalization
NewGen’s Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 MillionMidpoint equity value for planned UAE cell sorting entity highlights significant growth runway in high-infertility, medical-tourism hotspot
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million InvestedK25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion
NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital StructureNewGen to repurchase all outstanding convertible notes and warrants previously held by a significant investor in move to strengthen its capital structure
